Drug Profile
Epsi-gam
Alternative Names: Epsi gam; Fc fusion protein - Tunitas Therapeutics; GE2Latest Information Update: 28 Sep 2018
Price :
$50
*
At a glance
- Originator Tunitas Therapeutics
- Class Allergy immunotherapies; Antiallergics; Immunoglobulins; Recombinant fusion proteins
- Mechanism of Action Fc gamma receptor IIB antagonists; IgE receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Asthma; Food hypersensitivity; Hypersensitivity
Most Recent Events
- 28 Sep 2018 No recent reports of development identified for phase-I development in Allergy(In volunteers) in Australia (IV, Infusion)
- 28 Jan 2018 No recent reports of development identified for preclinical development in Asthma in Australia (SC)
- 28 Jan 2018 No recent reports of development identified for preclinical development in Food-allergy in Australia (SC)